Karl Luke

Karl Luke has a strong background in regulatory affairs and clinical research, with extensive experience in the healthcare industry. Karl worked at Quidel from 2013 to present as a Senior Director, overseeing the development and implementation of regulatory strategies for infectious disease product lines. Karl also provided technical guidance and support for international regulatory submission preparation. Prior to that, Karl worked at Diagnostic Hybrids, Inc. from 2006 to 2020 in various roles including Director of International Regulatory Compliance and Director of Quality Affairs. At Bayer HealthCare, Karl worked as a Staff Clinical Research Scientist and Study Manager from 1988 to 2005.

Karl Luke earned a Doctor of Philosophy (Ph.D.) degree in Health Care Considerations Used in the Development of In Vitro Diagnostic Test Systems from Madison University in Gulfport, MS. Karl completed their studies from 2001 to 2002.